ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Frazier LifeSciences Acquisition Corporation

Frazier LifeSciences Acquisition Corporation (FLAC)

9,87
0,00
(0,00%)
Geschlossen 31 Januar 10:00PM
9,87
0,00
( 0,00% )
Vor Marktöffnung: 1:00AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
9,87
Gebot
10,00
Fragen
12,75
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
9,87
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

FLAC Neueste Nachrichten

NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease

-- Business combination transaction with Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, completed on...

Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.

Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) (“FLAC”), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its...

Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors

FLORHAM PARK, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...

NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases

– Leading institutional investors commit approximately $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FLAC - Frequently Asked Questions (FAQ)

What is the current Frazier LifeSciences Acq... share price?
The current share price of Frazier LifeSciences Acq... is US$ 9,87
What is the 1 year trading range for Frazier LifeSciences Acq... share price?
Frazier LifeSciences Acq... has traded in the range of US$ 0,00 to US$ 0,00 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TDTHTrident Digital Tech Holdings Ltd
US$ 1,94
(104,21%)
2,49M
EDRYEuroDry Ltd
US$ 18,34
(63,75%)
8
KITTNauticus Robotics Inc
US$ 2,53
(62,18%)
6,61M
WVVIWillamette Valley Vineyards Inc
US$ 9,21
(60,17%)
12
OPOFOld Point Financial Corporation
US$ 39,05
(59,98%)
4
LNSRLENSAR Inc
US$ 5,01
(-53,74%)
100
HONEHarborOne Bancorp Inc
US$ 6,01
(-48,41%)
1
AVNWAviat Networks Inc
US$ 10,00
(-46,50%)
103
CEPOCantor Equity Partners I Inc
US$ 6,01
(-40,20%)
1
ENVBEnveric Biosciences Inc
US$ 2,38
(-38,97%)
53,97k
CLEUChina Liberal Education Holdings Ltd
US$ 0,1708
(15,25%)
9,12M
KITTNauticus Robotics Inc
US$ 2,53
(62,18%)
6,23M
TDTHTrident Digital Tech Holdings Ltd
US$ 1,93
(103,16%)
2,32M
RIMEAlgorhythm Holdings Inc
US$ 0,0255
(4,51%)
1,18M
SGBXSafe and Green Holdings Corporation
US$ 0,812
(16,00%)
1,15M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock